Lee Kai and Yangshun Partner on Polyvinyl Alcohol Embolization Microspheres
Chinese companies Shanghai Lee Kai Technology Co., Ltd (Kai Medtech) and Hangzhou Yangshun Medical Technology...
Deals
Nanos Medical Raises Over RMB300m to Boost Otolaryngology Device Lead
China-based Nanos Medical (Shanghai) Limited, an otolaryngology device maker, has reportedly raised over RMB300 million...
Trinomab’s Antitetanus mAb Injection TNM002 Approved by NMPA
China-based Trinomab Biotech Co., Ltd has received market approval for its antitetanus toxin monoclonal antibody...
Boehringer Ingelheim Partners with ExpressionEdits on Gene Therapy Tech
German pharmaceutical giant Boehringer Ingelheim has entered into a collaboration and licensing agreement with UK-based...
StairMed Raises Record RMB350m for Implantable BCI Development
Shanghai StairMed Technology Co., Ltd., a specialist in implantable brain-computer interface (BCI) technology, has reportedly...
J&J Considers Selling Stroke Care Business Cerenovus for USD1-1.5 Billion
US giant Johnson & Johnson (J&J, NYSE: JNJ) is reportedly considering selling its stroke care...
Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor
China – based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan...
AbbVie Collaborates with Xilio Therapeutics on Tumor-Activated Immunotherapies
US pharmaceutical giant AbbVie (NYSE: ABBV) has announced a collaboration and option-to-license agreement with fellow...
Andon Health to Fully Control iHealth by Acquiring Best Ventures’ Stake
China-based Andon Health Co., Ltd (SHE: 002432) announced a plan to obtain the 20% stake...
Liaoning Chengda Biotech to See Actual Controller Change of Controlling Shareholder
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) announced a proposed change in the actual...
Pfizer Partners with Alloy Therapeutics to Develop New Antibody Platform
US pharmaceutical giant Pfizer (NYSE: PFE) has entered into a multi-year partnership with compatriot firm...
Eli Lilly Expands Collaboration with AdvanCell on Targeted Alpha Therapies for Cancer
Eli Lilly & Co. (NYSE: LLY) has expanded its collaboration with Australia-based AdvanCell, a clinical-stage...
Eli Lilly Licenses OliX Pharma’s OLX75016 for MASH and Cardiometabolic Diseases
Eli Lilly & Co. (NYSE: LLY) has signed a licensing agreement with OliX Pharmaceuticals, Inc....
Kexing Biopharm and Bio-Thera Solutions Form Alliance for Global Expansion
China-based Kexing Biopharm (SHA: 688136) and Bio-Thera Solutions Ltd (SHA: 688177) have formed a strategic...
Novartis to Acquire Anthos Therapeutics for $3.1B, Boosting Factor XI Inhibitor Portfolio
Swiss pharma giant Novartis (NYSE: NVS) announced plans to acquire Anthos Therapeutics, Inc., a cardiometabolic-focused...
Roche Transfers InterMune and Esbriet to Legacy Pharma in IP Deal
Swiss pharma giant Roche (SWX: ROG) has transferred US-based InterMune, Inc., acquired for USD 8...
R-Nanoablation Raises USD 13.7M in Series B+ to Advance Nanosecond Ablation Tech
Hangzhou-based R-Nanoablation, a minimally invasive medical device developer, has raised over RMB 100 million (USD...
Bio-Thera Solutions Licenses BAT2506 to Intas Pharmaceuticals for US Market
China-based Bio-Thera Solutions Inc. (SHA: 688177) announced that it has entered into a licensing agreement...
Xtalpi Invests in Alternative Bio for Cancer and Inflammation Drugs
Shenzhen-based QuantumPharm Inc. (HKG: 2228), also known as Xtalpi Inc., announced a strategic investment in...
VectorBuilder and Eureka Bio Form Alliance to Advance CGT Solutions Globally
China-based gene delivery technology developer VectorBuilder has formed a strategic alliance with compatriot firm Shenzhen...